Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Depreciation & Amortization (CF) came in at $47002.0 in Q2 2026, down 29.42% on a YoY basis from $66594.0 in Q2 2025, and down 21.7% quarter-over-quarter from $60029.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Depreciation & Amortization (CF) for 8 consecutive years, with $47002.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 29.42% year-over-year to $47002.0; the trailing twelve-month figure through Jun 2026 stood at $236878.0 (down 9.41% YoY), and the FY2025 full-year result was $261679.0, up 6.03% from the prior year.
- Depreciation & Amortization (CF) eased to $47002.0 in Q2 2026 per NMTC's latest filing, from $60029.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $66594.0 in Q2 2025 and bottomed at $28531.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $54097.2 across 5 years, with a median of $60464.5 in 2024.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) soared 87.03% in 2023, then slipped 29.42% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $35889.0 in 2022, then soared by 63.44% to $58657.0 in 2023, then grew by 11.03% to $65127.0 in 2024, then gained by 0.61% to $65523.0 in 2025, then slipped by 28.27% to $47002.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $47002.0, $60029.0, and $65523.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Neuroone Medical Technologies | 14.10 Mn | 12.05 Mn | 1.18 Mn | 47,002.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47,002.00 |
| Mar 31, 2026 | 60,029.00 |
| Dec 31, 2025 | 65,523.00 |
| Sep 30, 2025 | 64,324.00 |
| Jun 30, 2025 | 66,594.00 |
| Mar 31, 2025 | 65,634.00 |
| Dec 31, 2024 | 65,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Jun 30, 2024 | 63,107.00 |
| Mar 31, 2024 | 60,900.00 |
| Dec 31, 2023 | 58,657.00 |
| Sep 30, 2023 | 62,509.00 |
| Jun 30, 2023 | 56,958.00 |
| Mar 31, 2023 | 43,910.00 |
| Dec 31, 2022 | 35,889.00 |
| Sep 30, 2022 | 33,422.00 |
| Jun 30, 2022 | 31,506.00 |
| Mar 31, 2022 | 28,531.00 |
| Dec 31, 2021 | 25,161.00 |
| Sep 30, 2021 | 22,363.00 |